Prana Biosciences Skyrockets On Parkinson's Drug Success

Forbes by Al Zheimer | Mar. 22, 2011 (News)

Prana Biotechnology today announced the publication of new data on the ability of PBT2 to repair the damage in an Alzheimer's affected brain thereby facilitating the restoration of cognition in Alzheimer's Disease. The findings help to explain the rapid improvement in cognition previously reported in transgenic Alzheimer's mice and in patients in a Phase IIa clinical trial. Full Story »

Posted by Dwight Rousu

More Info

Tags Help
Subjects: Business, Health
Topics: Pharmaceuticals
Stats Help
# Tweets: 27 (as of 2011-03-22)
Editorial Help
Posted by: Posted by Dwight Rousu - Mar 22, 2011 - 3:31 PM PDT
Reviewed by: Dwight Rousu (review)
Content Type: Article
Edit Lock: This story can be edited
Edited by: Dwight Rousu - Mar 22, 2011 - 3:33 PM PDT

Reviews

Show All Comments
Show All | Notes | Comments | Quotes | Links
Dwight Rousu
1.9
 by Dwight Rousu - Mar. 22, 2011

The news sounds exciting, but apparently the person who wrote the headline for this news had not taken the drug yet.

A little confusion between Alzheimer's and Parkinson's... How old is Steve Forbes?

Dwight posted this story.
See Full Review » (12 answers)

Comments on this story Help (BETA)

Sort by: Oldest | Newest Hide All Replies
NT Rating | My Rating

Ratings

1.9

not enough reviews
from 1 review (11% confidence)
Quality
1.8
Facts
2.0
Fairness
3.0
Sourcing
3.0
Style
1.0
Context
1.0
Depth
1.0
Enterprise
2.0
Relevance
2.0
Popularity
2.0
Recommendation
2.0
Credibility
2.0
# Reviews
1.0
# Views
5.0
# Likes
1.0
# Emails
1.0
More
How our ratings work »
(See these related stories.)

Links Help

No links yet. Please review this story to add some!